Fixní kombinace rosuvastanu s ezetimibem – lékový profil

Title in English Fixed dose combination of rosuvastatin and ezetimibe - drug profile

KYSELÁK Ondřej SOŠKA Vladimír

Year of publication 2018
Type Article in Periodical
Magazine / Source Kardiologická revue - Interní medicína
MU Faculty or unit

Faculty of Medicine

Keywords rosuvastatin; ezetimibe; LDL-cholesterol; cardiovascular diseases
Description Hypercholesterolemia is the major risk factor for atherosclerotic cardiovascular diseases (ASCVD), particularly myocardial infarction. Statins are essential drugs for treatment of patients with hypercholesterolemia, but in monotherapy they are usually not effective enough to achieve the target values of LDL cholesterol. Therefore it is recommended to combine statins with ezetimibe. This combination has proven good safety and efficiency. In addition, a fixed dose combination increases patient adherence to long-term treatment.

You are running an old browser version. We recommend updating your browser to its latest version.

More info